Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.5450 (1.89%) ($14.5450 - $14.5450) on Wed. Mar. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 32 | Latest Price | $14.5450(1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -7% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.43% in a week (0% probabilities). VIXM(-35%) VXX(-27%) IGOV(-16%) UNG(-11%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $2.73(-81.23%) | Inflection Point | Yes | Resistance Level | $15.54 | 5 Day Moving Average | $14.46(0.59%) | 10 Day Moving Average | $14.67(-0.85%) | 20 Day Moving Average | $15.54(-6.4%) | To recent high | -29.7% | To recent low | 4% | Market Cap | $1.081b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |